A novel formulation of zolpidem for direct nose‐to‐brain delivery: synthesis, encapsulation and intranasal administration to mice. (28th June 2018)

• Record Type: Journal Article
• Authors: Borodina, Tatiana; Marchenko, Irina; Trushina, Daria; Volkova, Yulia; Shirinian, Valerii; Zavarzin, Igor; Kondrakhin, Evgeny; Kovalev, Georgy; Kovalchuk, Mikhail; Bukreeva, Tatiana
• Is Part Of: Journal of pharmacy and pharmacology. Volume 70:Number 9(2018)
• Page Start: 1164
• Page End: 1173
• Publication Date: 2018-06-28
• Subjects: anxiolytic effect -- intranasal delivery -- microcontainers -- zolpidem; Pharmacy -- Periodicals; Pharmacology -- Periodicals; 615.1
• DOI: 10.1111/jphp.12958
• Languages: English
• ISSNs: 0022-3573

Abstract

Abstract: Objectives: Anxiolytic drug zolpidem was incorporated into the microcontainers based on mesoporous calcium carbonate particles modified by diethylaminoethyl‐dextran/hyaluronic acid shell. The release of zolpidem in saline solution and in polymer film modelling nasal mucosa was investigated. The anxiolytic effect of zolpidem upon intranasal administration of microcontainers and free medicine was determined by in vivo experiments on mice. Methods: The structures of all compounds during zolpidem synthesis were established using nuclear magnetic resonance spectroscopy. The loading efficacy and release kinetics of zolpidem were analysed by spectrophotometry. Surface morphology of formulation was investigated by scanning electron microscopy. To determine the effect of zolpidem‐loaded containers administration by the intranasal route in vivo experiments was carried out applying the open field test. Key findings: Nasal administration of zolpidem in the form of the microcontainers based on mesoporous calcium carbonate particles modified by diethylaminoethyl‐dextran/hyaluronic acid shell has a pronounced anxiolytic effect on the behaviour of the animals in the open field test. Conclusions: The polyelectrolyte shell deposited together with zolpidem enhances the loading efficacy of the microcontainers. In vivo experiments on mice demonstrate increase in anxiolytic effect of zolpidem in microcontainers compared with upon intranasal administration of free medicine.